| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/02/2004 | US6699676 Uses of ouabain and ouabain-like molecules in apoptosis related pathologies |
| 03/02/2004 | US6699660 Isolated nucleic acid identical to one expressed in response to seizure or ischemia |
| 03/02/2004 | US6699512 Hypericum perforatum l. oleoresin, procedure for obtaining it and uses of it |
| 03/02/2004 | US6699510 Chlorite solution and an acid or acidulant formulation with dye to indicate where applied and rheology modifier to immobilize the composition on the teat surface and provides a barrier; mastitis treatment |
| 03/02/2004 | US6699508 Sustained release oral preparations of fasudil hydrochloride |
| 03/02/2004 | US6699506 Pharmaceutical composition with extended release of Milnacipran |
| 03/02/2004 | US6699505 Wherein biological activity of bioactive agent/complexing agent complex is higher than activity of uncomplexed bioactive agent |
| 03/02/2004 | US6699498 Transdermal therapeutic systems having improved stability and their production |
| 03/02/2004 | US6699497 Permeation enhancer |
| 03/02/2004 | US6699495 Methods for treating multiple sclerosis employing desmethylselegiline |
| 03/02/2004 | US6699494 Side effect reduction |
| 03/02/2004 | US6699493 Performing the transplant, and implanting in the eye a biodegradable drug delivery system comprising an immunosuppressant and a biodegradable polymer |
| 03/02/2004 | US6699492 Quinolone carboxylic acid compositions and related methods of treatment |
| 03/02/2004 | US6699486 Treatment or prevention of photoaging and skin cancer |
| 03/02/2004 | US6699471 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders |
| 03/02/2004 | US6699467 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |
| 03/02/2004 | US6699461 UV-photostabilized sunscreen compositions comprising dibenzoylmethane/benzophenone compounds |
| 03/02/2004 | US6699460 UV-photostabilized sunscreen compositions comprising dibenzoylmethane/triazine/benzophenone compounds |
| 03/02/2004 | US6699459 Administering butylated hydroxyanisol to inhibit interferon regulatory factor activation |
| 03/02/2004 | US6699247 Spine distraction implant |
| 03/02/2004 | US6699246 Spine distraction implant |
| 03/02/2004 | US6698162 Methods of producing a terminally sterilized topical patch preparation |
| 03/02/2004 | CA2259449C Treatment of sepsis-induced acute renal failure and renal vasoconstriction and catecholamine-induced renal and mesenteric vasoconstriction |
| 03/02/2004 | CA2238789C Dual component tooth whitening dentifrice |
| 03/02/2004 | CA2221370C Composition for treating condyloma acuminata |
| 03/02/2004 | CA2198247C Ionene polymers containing biologically-active anions |
| 03/02/2004 | CA2196906C Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 03/02/2004 | CA2189007C Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
| 03/02/2004 | CA2158137C Therapeutic compositions containing a lithium compound and silica |
| 03/02/2004 | CA2138289C N-substituted azabicycloheptane derivatives, the preparation and use thereof |
| 02/26/2004 | WO2004016805A2 Immunostimulatory nucleic acids |
| 02/26/2004 | WO2004016783A1 Method of examining atopic dermatitis |
| 02/26/2004 | WO2004016764A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 02/26/2004 | WO2004016635A2 Partial and full agonists of a1 adenosine receptors |
| 02/26/2004 | WO2004016633A1 Salt of morphine-6-glucuronide |
| 02/26/2004 | WO2004016621A1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 02/26/2004 | WO2004016620A1 Polymorphic forms of dorzolamide chlorhydrate, production method thereof and pharmaceutical compositions containing same |
| 02/26/2004 | WO2004016619A1 Broadspectrum substituted oxindole sulfonamide hiv protease inhibitors |
| 02/26/2004 | WO2004016617A1 Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists |
| 02/26/2004 | WO2004016616A1 Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists. |
| 02/26/2004 | WO2004016614A2 Pyrrolopyrazines as kinase inhibitors |
| 02/26/2004 | WO2004016612A2 New purine derivatives |
| 02/26/2004 | WO2004016611A1 Use of and some novel imidazopyridines |
| 02/26/2004 | WO2004016610A1 Substituted pyrrolopyridines |
| 02/26/2004 | WO2004016609A1 Substituted pyrrolopyridines |
| 02/26/2004 | WO2004016608A1 Novel quinuclidine derivatives and their use |
| 02/26/2004 | WO2004016607A1 Inhibition of phosphoinositide 3-kinase beta |
| 02/26/2004 | WO2004016606A1 Pyrazole inhibitors of the transforming growth factor |
| 02/26/2004 | WO2004016601A1 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 02/26/2004 | WO2004016600A1 Novel use of benzothiazole derivatives |
| 02/26/2004 | WO2004016593A1 Diaryl compounds as monoamine reuptake inhibitors |
| 02/26/2004 | WO2004016587A1 Nitrogen-containing compounds |
| 02/26/2004 | WO2004016583A1 Substituted glycine derivatives for use as medicaments |
| 02/26/2004 | WO2004016581A1 Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile |
| 02/26/2004 | WO2004016580A2 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid |
| 02/26/2004 | WO2004016578A2 Arylethanolamine beta2-adrenoreceptor agonist compounds |
| 02/26/2004 | WO2004016289A1 Topical anhydrous and ethanol-free ascomycin compositions |
| 02/26/2004 | WO2004016287A1 Remedies for schizophrenia |
| 02/26/2004 | WO2004016277A2 Extraction of pharmaceutically active cannabinoids from plant materials |
| 02/26/2004 | WO2004016275A1 Separate type medical material |
| 02/26/2004 | WO2004016273A1 Shortening of hospital stay and improving survival in patients with chronic kidney disease |
| 02/26/2004 | WO2004016272A1 Use of reboxetine for the treatment of hot flashes |
| 02/26/2004 | WO2004016270A1 USE OF Itk INHIBITORS FOR THE TREATMENT OF MAST CELL-DRIVEN OR BASOPHIL-DRIVEN DISEASES |
| 02/26/2004 | WO2004016269A1 Use of vinca alkaloyds, taxane, cryptophycine, ephitoline or eleutherobine for treating alzheimer |
| 02/26/2004 | WO2004016268A1 Composition and method for controlling alcohol-induced facial flushing in susceptible humans |
| 02/26/2004 | WO2004016267A1 Anticoagulant and fibrinolytic therapy using p38 map kinase inhibitors |
| 02/26/2004 | WO2004016266A1 Methods of treating benzodiazepine site (bzd-s) associated syndromes using 2’ hydroxyflavonoids |
| 02/26/2004 | WO2004016265A1 Methods of predicting gabaa receptor efficacies for flavonoid compounds and uses therefor |
| 02/26/2004 | WO2004016264A1 Thrombopoetin receptor activator and process for producing the same |
| 02/26/2004 | WO2004016263A1 Use of treosulfan and derivatives thereof for treating multiple sclerosis |
| 02/26/2004 | WO2004016262A1 Amino acid-containing chewable |
| 02/26/2004 | WO2004016261A1 Method for suppressing proliferation of abnormal prion protein with leucine, isoleucine or valine |
| 02/26/2004 | WO2004016260A1 Therapeutic use of fused bicyclic or tricyclic amino acids |
| 02/26/2004 | WO2004016259A1 Synergistic combination of an alpha-2-delta ligand and a pdev inhibitor for use in the treatment of pain |
| 02/26/2004 | WO2004016258A1 Therapeutical use of guanylhydrazones for treating diseases associated with dendritic cell maturation |
| 02/26/2004 | WO2004016257A1 A composition comprising phytospingosine derivatives for apoptosis induction |
| 02/26/2004 | WO2004016256A2 AGONISM OF THE 5HT2a RECEPTOR FOR TREATMENT OF THERMOREGULATORY DYSFUNCTION |
| 02/26/2004 | WO2004016255A1 The use of resveratrol to regulate expression of apolipoprotein a1 |
| 02/26/2004 | WO2004016254A2 Contraceptive methods and formulations |
| 02/26/2004 | WO2004016253A1 Use of nf-kappa b inhibitors for the treatment of mastitis |
| 02/26/2004 | WO2004016251A1 Sustained release pharmaceutical composition of a cephalosporin antibiotic |
| 02/26/2004 | WO2004016250A1 Sustained release pharmaceutical composition of a cephalosporin antibiotic |
| 02/26/2004 | WO2004016244A2 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 02/26/2004 | WO2004016243A2 Methods of administering and enhancing absorption of pharmaceutical agents |
| 02/26/2004 | WO2004016242A2 A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles |
| 02/26/2004 | WO2004016238A1 Antiaging composition |
| 02/26/2004 | WO2004016221A2 Sulfonamides as potassium channel blockers |
| 02/26/2004 | WO2004016214A2 Methods and compositions for treatment of macular and retinal disease |
| 02/26/2004 | WO2004016213A2 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 02/26/2004 | WO2004016211A2 Pi3k antagonists as radiosensitizers |
| 02/26/2004 | WO2004016101A2 Compositions comprising dietary fat complexer and methods for their use |
| 02/26/2004 | WO2004016100A2 Nutritional supplement for adolescents |
| 02/26/2004 | WO2004016086A2 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
| 02/26/2004 | WO2004004650A3 Antibacterial formulations |
| 02/26/2004 | WO2004002423A3 Cartilage enhancing food supplements with sucralose and methods of preparing the same |
| 02/26/2004 | WO2004000237A3 Enhancing treatment of mdr cancer with adenosine a3 antagonists |
| 02/26/2004 | WO2004000034A3 Anthelmintic oral homogeneous veterinary pastes |
| 02/26/2004 | WO2003106505A9 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 02/26/2004 | WO2003104217A3 Prodrugs of excitatory amino acids |